GKOS

Announcements

Nothing here yet

Daily updates

• Glaukos reported positive topline Phase 4 results showing that iDose TR used with cataract surgery significantly outperformed cataract surgery alone in reducing mean diurnal intraocular pressure in patients with open-angle glaucoma or ocular hypertension.Oct 9, 2026

FDA designations

Nothing here yet

News

• Glaukos reports positive topline results from a Phase 4 randomized controlled trial evaluating iDose TR alongside cataract surgeryOct 9, 2026
• Glaukos completes patient enrollment in pivotal 510(k) study for PRESERFLO MicroShuntJul 27, 2026
• Glaukos received FDA approval for iDose TR re-administrationJan 28, 2026
• Glaukos announces FDA approval of Epioxa™Oct 20, 2025